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Summary 
Human memory B cells that carry mutated IgV region 
genes were isolated from tonsils by negative selection 
of IgD+ naive B cells and CD38+ germinal center B 
cells and plasma cells. They were mainly found within 
the intraepithellal areas, but not in the B cell follicles 
of human tonsils. Memory B cells but not naive B cells 
have the capacity to present antigen directly to T cells, 
owing to the constitutive expression of the accessory 
molecules B7-l/CD80 and B7-2/CD88. Signals through 
antigen receptorsand CD40 antigen result in these two 
molecules being further upregulated more rapidly and 
strongly on memory B cells than on naive B cells. The 
unique anatomlcal localization of memory B cells be- 
neath the surface of mucosa, together with their strong 
APC capacity, may explain the well-known prompt and 
robust secondary antibody responses. 
Introduction 
The principle of vaccination to prevent diseases depends 
entirely on immunological memory that is carried out by 
memory B lymphocytes and memory T lymphocytes (Ra- 
jewsky, 1989; MacLennan and Gray, 1986; Vitetta et al., 
1991; Gray, 1993; Gray and Sprent, 1990; Mackay, 1993; 
Sprent, 1994). To date, while the expression of different 
CD45 isoforms has been very useful to define memory T 
cells (CD45RO+) versus naive T cells (CD45RA+) in certain 
circumstances (Beverley, 1990), there appears to be no 
specific marker for memory B cells. In our previous study, 
human memory B cells were isolated from tonsillar B cells 
by negative depletion of immunoglobulin D-positive (IgD+) 
naive B cells and CD38+ germinal center (GC) B cells and 
plasma cells (Liu et al., 1994). Sequence analysis of IgV 
region genes showed extensive somatic mutations, thus 
indicating at the molecular level the GC origin of these 
memory B cells (Pascual et al., 1994). 
One of the fundamental questions about immunological 
memory remains: why do secondary antibody responses 
occur more robustly and rapidly than primary antibody re- 
sponses. Two hypotheses have been put forward to explain 
this paradox (Rajewsky, 1989; MacLennan and Gray, 
1986; Vitetta et al., 1991; Gray, 1993; Gray and Sprent, 
1990; Mackay, 1993; Sprent, 1994): according to the clas- 
sical clonal selection theory of Burnet (1959), primary im- 
munization generates a large pool of antigen-specific B 
cells, which can participate in secondary responses; pri- 
mary immunization may also lead to many intrinsic differ- 
ences between memory B cells and naive B cells, such 
as receptor repertoire, capacity of antigen presentation, 
requirements for activation and tolerance, homing pat- 
terns, and lifespan. However, until now, the only definitive 
marker of memory B cells has been the somatically mu- 
tated high affinity antigen receptors (Weiss and Rajewsky, 
1990; Jacob et al., 1991; Berek et al., 1991; McHeyzer- 
Williams et al., 1993; Kijppers et al., 1993; Pascual et al., 
1994). Herein, we have compared phenotype and function 
of highly purified human memory B cells, naive B cells, 
and GC B cells. The present study demonstrates that 
memory B cells are potent antigen-presenting cells 
(APCs), owing to their constitutive expression and rapid 
up-regulation of the accessory molecules 87-l (defined 
as CD80) and 87-2 (defined as CD86). lmmunohistological 
analysis shows that these memory B cells preferentially 
colonize the tonsil epithelium, the potential site of antigen/ 
pathogen entry. 
Results 
lgDCD38- Memory B Cells Have a Surface 
Phenotype Distinct from lgD+CD38- Naive 
B Cells and lgDCD38+ GC B Cells 
To characterize fully their phenotype, lgDCD38- memory 
B cells (Figure 1A) were isolated by negative depletion 
of IgD+ and CD38+ B cells with immunomagnetic beads 
(Pascual et al., 1994). In addition, lgD+CD38- naive B cells 
(Figure 1A) were isolated by negative depletion of CD38+, 
IgG+, and IgA+ B cells or by positive selection of IgD+ B 
cells, while lgDCD38’ GC B cells (Figure 1A) were iso- 
lated by depletion of IgD+ and CD39+ B cells. The following 
groups of monoclonal antibodies (MAbs) were used for 
the phenotyping: MAbs selectively staining naive follicular 
mantle (FM) B cells: anti-IgD, CD23, CD39, and CD44 
(Ling et al., 1987); MAbs staining GC B cells: anti-CDlO, 
CD38, and CD77 (Ling et al., 1987); MAbs specific for 
CD20 (a pan-B cell antigen), IgG, IgM, and IgA; MAbs 
specific for the accessory molecules 87-l and 87-2; MAbs 
specific for survival/death gene proteins Bcl-2 and Fas; 
and the MAb specific for the proliferating nuclear antigen 
Ki67. Figure 1B shows that lgDCD38- memory B cells 
express neither the GC B cell markers CD10 and CD77 
nor the FM marker CD23. They express CD20, CD39, 
CD44, and high levels of IgG, which correlate with the 
phenotype of recently identified tonsillar B cell subset ex- 
pressing CD44 but not CD38 (Lagresle et al., 1993) or 
IgA expressing B cells from peripheral blood (Irsch et al., 
1994). Thus, lgDCD38- memory B cells have a surface 
phenotypic profile distinct from both naive B cells and GC 
B cells. The expressions of 87-1, B7-2, Ki67 antigen, Fas, 
and Bcl-2 shown in Figure 1B will be discussed in the 
following related sections. 
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Figure 1. Phenotype of Naive, Germinal Cen- 
ter, and Memory B Cells 
(A) Double staining of tonsil B cells with anti- 
IgD and anti-CD38 showing three major B cell 
sub&e. 
(9) Phenotypic analysis of three B cell subsets 
isolated by negative depletion with immune 
magnetic beads. IgD+CD38 FM B cells were 
isolated from purified tonsil B cells by depletion 
of CD38+, IgG+, and IgA+ B cells with immuno- 
magnetic beads (Liu et al., 1994). IgDCD38+ 
GC B cells were isolated by depletion of IgD+ 
and CD39’ B cells (Liu et al., 1989). lgDCD38 
B cells were isolated by depletion of lgD+ and 
CD38+ B cells (Liu et al., 1994). 
IgD-CD38- Memory B Cells Are Resting B Calls proliferating cells) and to their morphological characteris- 
that Dften Display Dendrites tics after Giemsa staining. Figure 2A shows that only 3% 
The expression of mutated IgV genes by IgD-CDW mem- of IgDCDS memory B cells express the Ki87 nuclear 
ory B cells demonstrated their GC origin (Pascual et al., antigen, compared with 5% of lgD+CD38- naive B cells 
1884). To confirm further that they are not proliferating GC and 66% of lgDCD38+ GC B cells. The same results were 
B cells, their cell cycle status was determined according to obtained from flow cytometry analysis (see Figure lB), 
the expression of nuclear Ki67 antigen (characteristics of showing that GC B cells express much higher levels of 
lgD+CD38’ (naive) lgD’CD38’ (memory) lgD’CD38+ (GC) 
Figure 2. Expression of Ki87 Antigen and Morphological Features of Naive, Germinal Center, and Memory B Cells 
(A) Selective expression of proliferating nuclear antigen Ki87 on IgD-CD38+ GC B cells, but not on lgD+CD38- naive B cells and IgD-CD38 memory 
B cells (btue alkaline phosphatase staining; magnification, 138x). The average percentages of Ki87+ cells from four different experiments with 
ranges in brackets are indicated in the upper right corner of the pictures. 
(9) Morphological characterization of three subsets of B cells by Giemsa staining (magnification, 898x). IgD+CD38 naive B cells are small 
lymphocytes; IgDCDW B cells are large lymphocytes wtth cleaved nuclei; IgDdDW memory B cells are medium-sized lymphocytes with 
characteristic dendrttic processes. 
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Figure 3. Anti-FasTriggering Accelerates Apoptosis in IgD-CD3E’GC 
B Cells but Does Not Induce Apoptosis in Either lgD+CD3W Naive B 
Cells or IgD-CD=- Memory B Cells over a 24 hr Culture 
Cells (lq from each subset were cultured in 1 ml of RPM 1640 ma 
dium with 10% FCS containing either 0.1 &ml mouse IgM control 
antibody (closed bars) or 0.1 &ml anti-Fas antibody (hatched bars) 
in 24-well flat-bottomed plates. This figure shows the percentages of 
B cell from the three subsets displaying apoptotic figure after 4 hr, 12 
hr. and 24 hr of culture. Apoptotic calls are characterized by chromatin 
condensation and nuclear fragmentation revealed by Giemsa staining 
(Figure 4). The accuracy of such analysis has been confirmed by DNA 
fragmentation analysis(Liu et al., 1989). Thisfigureshows 1 of2experi- 
ments. 
Ki67 antigen than either naive B cells or memory B cells. 
It indicates that IgD-CD38- memory B cells are resting 
cells. However, Giemsastaining shows that these memory 
B cells have a morphology different from that of naive B 
cells or GC 6 cells: memory B cells are medium-sized 
lymphocytes, often with short dendritic processes, while 
naive B cells are small round lymphocytes and GC B cells 
are large round lymphocytes with characteristic nuclear 
cleft (Figure 28). 
IgD-CD38- Memory B Cells Constltutively Express 
Bcl-2 and Fas and Undergo Neither Spontaneous 
Nor Anti-Fas-Mediated Apoptosls 
Since memory B cells are derived from GC B cells, which 
are prone to spontaneous apoptosis in vitro, the expres- 
sion of survival gene Bcl-2 protein (Korsmeyer, 1992) and 
death-trigger Fas (lrauth et al., 1989; ltoh et al., 1991) 
was analyzed on memory B cells in comparison with GC 
B cells and naive B cells. Figure 1 shows that GC B cells 
express Fas but not Bcl-2 protein, while naive B cells ex- 
press Bcl-2 but not Fas. Interestingly, memory B cells ex- 
press both Bcl-2 protein and low levels of Fas. To look at 
the functional consequencesof this differential expression 
of survival/death genes, spontaneous and anti-fas-medi- 
ated apoptosis of the three B cell subsets cultured for 24 
hr were analyzed by Giemsa staining of cytospin prepara- 
tions. Figure 3 shows that GC B cells undergo rapid spon- 
taneous apoptosis as reported before (Liu et al., 1989), 
with 43% of GC cells displaying apoptotic figures after 4 
hr of culture, 81% after 12 hr, and over 99% after 24 hr. 
In contrast, over 50% of both naive B cells and memory 
B cells remained viable after 24 hr of culture. Strikingly, 
addition of anti-Fas antibody accelerated the apoptotic 
process of GC B cells (Figure 3), resulting in 87% of apop 
totic GC B cells after 4 hr of culture. In contrast, anti-Fas 
antibody did not induce apoptosis in either naive B cells 
or memory B cells after 24 hr of culture (Figure 3). Figure 
4 shows Giemsa staining of GC B cells cultured for 4 hr 
with IgM control antibodies, GC B cells cultured for 4 hr 
with anti-Fas antibody, and memory B cells cultured for 
12 hr with anti-Fas antibody. 
Thus, IgD-CD38- memory B cells have undergone so- 
matic mutations, been rescued from apoptosis (Bcl-2+), 
and differentiated into Ki67- resting memory B cells. 
IgD-CD38- Memory B Cells Produce Tetanus 
Toxoid-Specific Antlbody after Activation 
The major goal of vaccination is to inducespecificantibody 
responses and to generate and maintain memory T and B 
cells. To prove functionally that IgD-CD38- B cells indeed 
represent memory B cells, the anti-tetanus toxoid (lT) anti- 
body response was analyzed from two tonsil samples of 
4-year-old children, who had been immunized with lTvac- 
tine four times during the first 2 years of age. Purified B 
cell populations were costimulated in a CD4Odependent 
system (Banchereau et al., 1991) in the presence of SAC, 
interleukin-2 (IL-2), and IL-lo, a combination that triggers 
all tonsil B cells to produce high levels of immunoglobulin 
(Fluckiger et al., 1993). The lgD+CD38- FM B cells pro- 
duced high levels of total immunoglobulin (data not 
shown), but did not produce detectable specific anti-n 
antibodies. In contrast, IgD-CD38- B cells from the two 
donors produced 40.3 mu/ml and 3,5 mU/ml IgG anti-l-f 
antibodies. IgD-CD38+ GC B cells produced lower but sig- 
nificant amounts of anti-lT antibodies (9.7mUlml and 2.3 
mU/ml). 
IgD-CD38- Memory B Cells Constitutively Express 
87-l and 87-2 and Are Potent APCs 
Since antigen presentation is a primary and key step to 
initiate immune responses, the expression of the costimu- 
latory molecules 87-l and 87-2 (Chiodetti and Schwartz, 
1992;Azumaetal.,1993a;Freemanetal.,1993;Hathcock 
et al., 1993; Linsley and Ledbetter, 1993; Clark and Led- 
better, 1994; June et al., 1994; Allison, 1994; Seder et al., 
1994) and antigen-presenting capacity of memory B cells 
was compared with that of naive and GC B cells. Flow 
cytometry analysis shows that memory B cells and GC B 
cells constitutively express 87-l and 87-2, while naive B 
cells only express low level of 87-2 (see Figure 1B). In 
keeping with this differential expression of the costimula- 
tory molecules, IgD-CD38- memory B cells and IgD- 
CD38+ GC B cells induced strong CD4+ allo-Tcell prolifer- 
ation, while lgD+CD38- naive B cells failed to do so (Figure 
5A). The strong proliferation of CD4+ allo-T cells induced 
by memory B cells was blocked partially by antibody to 
87-2 and totally by a combination of antibodies against 
the 87-l and B7-2 (Figure 58). 
IgD-CD38- Memory B Cells Rapidly 
Up-Regulate 87-l and 87-2 after 
Antigen-Receptor Triggering 
The first event of humoral immune responses is antigen 
capturing by B cells and other APCs. Memory B cells are 
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Figure 4. Morphological Characterization of Apoptotic Cells 
Giemsa staining of GC B cells after 4 hr of culture with either IgM control antibody or with anti-Fas and memory B cells after 12 hr of culture with 
anti-Fas. The viabilities of the three B cell subsets before culture are always over 95%. This figure represents 1 of 2 experiments. 
more effective than naive B cells in capturing small 
amounts of antigen and processing it rapidly (Vitetta et 
al., 1991). Since triggering of antigen receptors rapidly 
induces 87-l and 87-2 expression on B lymphocytes 
(Boussiotis et al., 1993; Lenschow et al., 1994), we looked 
at whether the three B cell subsets would up-regulate 87-l 
and 87-2 during a 48 hr culture with anti-19 K + h light 
chains presented on CD32-transfected mouse L cells. Fig- 
ure 8 shows that immunoglobulin receptor cross-linking 
essentially up-regulates 87-l and 87-2 on memory B cells 
(anti-B7-1 antibody 307 and anti-B7-2 antibody IT2 directly 
conjugated with phycoerythrin were used for the detec- 
tion). Up-regulation can already be detected after 12 hr 
of culture and peaks between 24 and 48 hr. Since anti- 
immunoglobulin can only maintain good survival of GC B 
cells for 24 hr (Liu et al., 1989) the expression of 87-l 
and 87-2 can not be analyzed on GC B cells after 48 hr 
of culture. Low level 87-2 up-regulation on naive B cells 
was only observed after 48 hr of culture. 
In Contrast with Memory B Cells, Naive B Cells 
Poorly Express 87-l and 87-2 after Culturing 
with CD40-Ligand Transfected L Cells 
or Allo-Specific T Cell Lines 
CD40-ligand expressed on early activated T cells turns 
on B cell activation (Banchereau et al., 1994; Clark and 
Ledbetter, 1994; Armitage et al., 1992). In particular, 
CD40-ligand-activated human B cells rapidly express 
87-l and 87-2 (Azuma et al., 1993b; Yellin et al., 1994). 
Figure 7 shows that 87-l and 87-2 are up-regulated on 
all three subsets of B cells between 8-12 hr, reaching 
maximal expression after 24 hr of CD40-ligand stimula- 
tion. Levels of 87-l and 87-2 on naive B cells were much 
lower than those on either memory B cells or GC B cells. 
This low 87-l and 87-2 expression on naive B cells in- 
duced by CD40-ligand was further confirmed by indirect 
immunofluorescence stainings using four different anti- 
B7-l/CD80 antibodies, 104, 307, 308, and BBl, and the 
same anti-B7-2/CD88 antibody IT2 (Figure 8). Finally, the 
expression of 87-l and 87-2 on three B ceil subsets during 
the cognate interaction with a CD4+ allo-specific T cell line 
was studied. As illustrated in Figure 9, specific T cell lines 
induced a strong and rapid up-regulation of both 87-l and 
87-2 on memory B cells and GC B cells but not on naive 
B cells. 
IgD-CD38- Memory B Cells Are Mainly Located 
within Tonsillar Epithelium 
The anatomical distribution of memory B cells was deter- 
mined by immunohistology. Figure 10a shows a human 
tonsil section double stained with anti-IgD (red) and anti- 
CD38 (blue), where FM B cells are red (lgD+CD38-), while 
Figure 5. IgD-CD36- Memory B Cells and IgD-CD36’ GC B Cells, but 
Not lgD+CD36- Naive B Cells Induce Strong Proliferation of CD4+ 
Allo-T Cells 
(A)Tcells(2.5 x 10’)werecultured withdifferent numbersof irradiated 
(60 Gy) B cells for 6 days. The cells were pulsed with 1 uCi of PHjthymi- 
dine for 16 hr before harvesting and counting. 
(8) Memory B cell (12.5 x lO’cells)-induced CD4+ allo-Tcell prolifera- 
tion is blocked by antibodies against B7-i/CD60 (306) and B7-2/CDS6 
(IT2) at 5 ug/ml. This figure represents 1 of 4 experiments. 
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Figure 6. Anti-lmmunoglobulin Triggering Rapidly Up-Regulates Lev- 
els of 87-l and B7-2 on Memory B Cells 
B cells (IO? were cultured in 1 ml of RPM 1640 medium with 10% 
FCS containing 2 pg/ml anti-IgK and 2 ug/ml anti-lg5 antibodies. These 
antibodies are presented on CDIP-transfected murine fibroblasts to 
cross-link the antigen receptors on B cells (6 cell to fibroblast ratio is 
1O:l and the fibroblasts were irradiated at adoseof 75Gy). Expression 
of 87-l and 87-2 was analyzed by direct immunofluorescence after 
6 hr (data not shown), 12 hr, 24 hr, and 46 hr of culture. The levels 
of 87-l and 87-2 before culture are shown by shaded histograms. GC 
B cells can not be analyzed at 46 hr after culture, since no viable cells 
can be recovered. This figure represents 1 of 4 experiments. 
GC 6 cells are blue (lgDCD38+). To localize lgDCD38- 
memory 6 cells, double staining on an adjacent section 
was done using three antibodies, including a blue anti-IgD 
together with a blue anti-CD38, as well as a red antiCD20. 
Thus, memory lgDCD38- B cells should be stained red, 
while lgD+CD38- FM B cells and lgDCD38+ GC B cells 
should be double stained purple. Accordingly, most FM 
and GC cells were stained purple (Figure 1 Oc), while about 
50% of B cells within tonsil epithelium were IgD- CD38- 
CD20’ red memory B cells (Figure lOd, showing higher 
magnification). The phenotype and mutated IgV gene sta- 
tus of isolated memory B cells support the conclusion that 
most of them are located outside B cell follicles: they ex- 
press CD39 and 6~1-2 proteins that are not detected within 
germinal centers (Ling et al., 1987; Liu et al., 1991a); most 
of the cells directly sampled from FMs have germline IgV 
genes (Kiippers et al., 1993) in contrast with the mutated 
IgV genes of memory B cells. 
Discussion 
Our current studies demonstrate at the molecular and 
functional levels that lgDCD38- B cells are memory B 
cells that have undergone somatic mutation in their IgV 
genes (Pascual et al., 1994) and that can be restimulated 
to produce antigen-specific antibodies. Three unique fea- 
tures could be identified on these memory B cells. 
First, tonsillar memory B cells express both Bcl-2 and 
Fas, while naive B cells only express 6~1-2. Thus, following 
positive selection and differentiation of high affinity GC B 
Figure 7. Anti-CD40 Triggering Up-Regulates 87-l and 87-2 More 
Rapidly on Memory B Cells and GC B Cells than on Naive B Cells 
B cells were cultured with irradiated human CD40-ligand-transfected 
murine fibroblasts at ratio of 5 B cells to 1 fibroblast. Expressions of 
87-l and 87-2 before culture (shaded histograms), after 6 hr, 12 hr, 
and 24 hr of culture were analyzed by direct immunofluorescence 
using anti-B7-I (306) and anti-87-2 (IT2) directly conjugated with phy- 
coerythrin. This figure represents 1 of 4 experiments. 
cells, resulting memory B cells up-regulate Bcl-2 but do not 
fully down-regulate Fas. Interestingly, the Fas-expressing 
memory B cells are resistant to anti-Fas-induced apoptosis 
during 24 hr of in vitro culture, a property also shared by 
Fas-expressing memory T cells (Miyawaki et al., 1992). It 
is important to determine the function of Fas on memory 
B and T cells, particularly in the context of a proliferative 
signal, as anti-Fas has been shown to enhance prolifera- 
tion of normal T lymphocytes (Alderson et al., 1993). 
Second, tonsillar memory B cells are potent APCs. This 
confirms previous experiments showing that naive B cells 
can not present antigen to T cells before becoming acti- 
vated (Ron and Sprent, 1987; Liu and Janeway, 1991; 
Eynon and Parker, 1992; Mamula and Janeway, 1993; 
Cassell and Schwartz, 1994). Our obsenration that mem- 
ory B cells but not naive B cells constitutively express 
both 67-1 and 87-2 offers an explanation for the potent 
antigen-presenting capacity of memory B cells, as it has 
been shown that presenting antigen without costimulating 
molecules lead to tolerance induction or death (Jenkins 
et al., 1988; Liu and Janeway, 1992; Gimmi et al., 1993; 
Tan et al., 1993; Janeway and Bottomly, 1994). This was 
further confirmed by the blocking of memory B cell to in- 
duce allo-T cell proliferation by antibodies against 87-l I 
CD80 and B7-2/CD88. Interestingly, the constitutive ex- 
pression of 87-l and 67-2 on memory Bcells can be further 
up-regulated after triggering through antigen receptor, 
CD40 antigen, or during the direct interaction with T cells. 
In contrast, naive B cells express 87-l and 87-2 only after 
CD40 triggering, and at a lower levels. These data support 
the previous finding that naive B cells can not present 
antigen directly to T cells. In fact, T cells need first to be 
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Figure 9. Indirect lmmunofluorescence Confirms the High Levels of 
87-l and 87-2 on Memory B Cells and GC B Cells Compared with 
Naive B Cells at 48 hr after CD40 Triggering 
We used four different MAbs for B7-1 (104, L307, L309, and BBl) and 
the MAb IT2 for 87-2. The secondary antibody used is anti-mouse 
immunoglobulin conjugated with PE. This figure represents the result 
from 1 of 4 experiments. 
Figure 9. Expression of 87-l and 87-2 on Three Subsets of B Cells 
after Coculturing with Allo-Specific T Cells 
Three subsets of B cells were isolated and frozen in FCS containing 
20% DMSC at -190%. An Epstein-Barr virus-transformed B cell line 
was generated from the same tonsils. A CD4+ allo-specific T cell line 
was generated by culturing allcgeneic CM+ T cells from peripheral 
blood with the Epstein-Ban virus B cell line, 11-2, and phytohemagglu- 
tinin. Once the CD4+ allmifrc T cell line was generated, cells were 
cultured with three subsets of B cells at ratio of 1 T cell to I B cell. 
Double immunofluorescence staining with anti-B7-I-PE or anti-B7-2- 
PE plus antiCDPO-FITC were performed. The kinetics of B7-l/CD90 
and B7-2/CD99 expressions on CD29+ B cells were analyzed by flow 
cytometry and expressed as mean fluorescence intensity (MFI). The 
presented results are from 1 of 4 experiments. 
Figure 10. In Situ Localization of lgDCD39- Memory B Cells on Tonsil Tissue Sections 
(a) Double anti-IgD (red) and antiCD39 (blue) staining showing two secondary follicles with red lgD+CD39 FMs and blue lgD%D39+ GCs. The 
above tonsillar epithetial area contains a few red lgD+CD39- cells and blue lgD‘CD39+ cells (magnification. 31.2x). 
(b) A part of epithelial area of (a) (boxed) at a higher magnification (magnification, 159x). 
(c) Double blue antElgD, blue antiCD39, and red anti-CD20 staining showing double stained (purple cotor) secondary follicles. The above epithelial 
areas contain many red tgDCD39CD20+ cells (magnification, 31.2x ). 
(d) The same part of epithelial area as shown in (b) contains many red lgD%D39%D20* memory B cells (magnification, 156x). 
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Table 1. The Clone Numbers, Isotypes. and Sources of the 
Antibodies Used 
A. Antibodies Clone Source 
CD2 (FITC) 39 Cl .5 lgG2a (rat) lmmunotech 
CD3 (FITC) UCHT 1 IgGl lmmunotech 
CDIO-FITC W8 E37 IgG2a Becton-Dickinson 
CDIQ-FITC RMO 52 IgG2a lmmunotech 
CD1 9-FITC J4119 Wl lmmunotech 
CD20-FITC IOB 20b WI lmmunotech 
CD23-PE B-G6 WI Serotec 
CD36 T IO IgGl lmmunotech 
CD36-PE HB-7 IgGl Becton-Dickinson 
CD39 (biotin) AC-2 IgGl B.D.S. 
CD44-FITC NaM lO-6F4 IgGl Diagast 
CD71-FITC IOA 71 IgGl lmmunotech 
CD77 sup. 36-13 IgM (rat) lmmunotech 
FAS-FITC UB2 IgGl lmmunotech 
FAS CH 11 I9M lmmunotech 
Bol2-FCTC IgGl Dako 
Ki67-FITC IgGl Dako 
87-l 307 IgGl DNAX 
87-l 306 I9M DNAX 
87-l BBl IgGl Becton-Dickinson 
87-l 104 IgGl Schering-Plough 
87-l -PE 307 IgGl DNAX 
87-2 IT2 IgGl DNAX 
B7-2-PE IT2 IgGl DNAX 
K light chain IgGl lmmunotech 
1 light chain IgGl lmmunotech 
IgD biotin IgGl Amersham 
IgA pur. IgGl Serotec 
IgG pur. IgGl Serotec 
Goat anti-mouse-FITC IgG + IgM Bioart 
Goat anti-rat-FITC I9M Nordic 
Streptavidin-PE Becton-Dickinson 
Streptavidin-FITC lmmunotech 
Streptavidin-Tricolor Caltag 
8. lmmunoglobulin lsotype Controls 
Mouse IgGl Biot. Caltag 
Mouse IgM lmmunotech 
Rat IgGPa FITC lmmunotech 
Mouse IgGl FITCIPE lmmunotech 
Mouse IgGPa FlTClPE lmmunotech 
primed to express CD40-ligand (Banchereau et al., 1994; 
Clark and Ledbetter, 1994) by professional APCs, such 
as dendritic cells that express 87-l and 87-2 constitutively 
(Caux et al., 1994; lnaba et al., 1994). Then, the CD40- 
ligand expressing T cells may induce naive B cells to ex- 
press 87-l and 87-2 and to become immunocompetent. 
Third, tonsillar memory B cells were found mainly within 
the epithelium. Actually, intraepithelial B cells displaying 
dendritic morphology have been reported before and were 
named as monocytoid B cells or asteroid B cells. (Miiller 
and Mielke, 1989). Interestingly, tonsillar lgDCD38- mem- 
ory B cells isolated herein were found to display many 
dendrites (Figure 28). In keeping with this, a close link 
has been established between these intraepithelial B cells 
and extranodal B cell lymphoma that arise in organs with 
mucosa-associated lymphoid tissue, such as the gut, lung, 
salivary gland, thyroid glands, and breast. The remarkable 
intraepithelial localization of memory B cells parallels that 
of memory CD45RO+ T cells, which preferentially colonize 
the skin, the mucosa, and the inflammatory tissues 
(Mackay, 1993). Thus, it might be a common strategy for 
some memory B cells as well as some memory T cells to 
colonize antigen-draining sites. Consistent with this hy- 
pothesis, memory B cells generated in the spleen were 
shown to colonize the splenic marginal zones, which are 
the draining sitesof blood-borne antigens (Liu et al., 1988). 
Whether intraepithelial memory B cells display migration 
capacity remains to be established. In fact, not all memory 
B cells are able to recirculate, as shown by their resistance 
to prolonged thoracic duct cannulation (Gowans and Uhr, 
1988). These nonrecirculating memory B cells may be en- 
gaged in continuous local responses to residual depots 
of antigens (Sprent, 1994). Finally, memory B cells from 
the splenic marginal zone do not recirculate unless trig- 
gered by antigen (Liu et al., 1988,199lb; MacLennan and 
Liu, 1991). 
In conclusion, the present study has provided a pheno- 
typic and functional analysis of lgDCD38- B cells that 
qualifies them as resting memory B cells. Their unique 
localization beneath the mucosal surface and their potent 
antigen-presenting capacity, confered by the constitutive 
expression and rapid up-regulation of 87-l and 87-2, pro- 
vide a basic mechanism for rapid and robust secondary 
humoral immune responses. 
Experlmental Procedures 
Antlbodles 
The details of antibodies (clone number, isotype, and source) used 
for phenotyping and immunomagnetic bead depletion are listed in 
Table I. 
Isolation of Tonslllar B Cells 
Tonsil B cells were prepared as previously described (Fluckiger et al., 
1993). In brief, tonsils taken from patients during routine tonsillectomy 
were finely minced and the resulting cell suspension was subjected 
to two rounds of depletion of non-B cells: T cells were depleted by 
rosetting with sheep red blood cells; the residual non-B cells were 
depleted by T cell-specific antibodies (CD2, CD3, CD4) followed by 
magnetic beads coupled with anti-mouse IgG (Dynabeads, Dynal. 
Oslo, Norway). The resulting cells from all the experiments contain 
more than 96% CD19+ B cells. 
Separation of Tonsll B Cells Into Hlgh Dens&y and Low Density 
B Cells on Percoll Gradient 
Some tonsil B cells were further separated into high density B cells 
and low density B cells bycentrifugation through 15%, 60%, and 65% 
Percoll gradient (Pharmacia. Uppsala, Sweden). In brief, the 100% 
Percoll is prepared by mixing 90 ml of Percoll (Pharmacia, Uppsala, 
Sweden) with IO ml of 10x concentrated phosphate-buffered saline 
(PBS). The 15% Percoll solution is prepared by mixing 15 ml 100% 
Percoll with 65 ml PBS. The 60% and 65% Percoll solutions are pre- 
pared accordingly. The discontinuous PercoIl gradient is generated 
by layering 3 ml 60% Percoll on top of 3 ml 65% Percoll in a 15 ml 
Falcon tube (Becton Dickinson). Afterwards, 2 ml of 15% Percoll are 
deposited on top of the 66% Percoll. Then, 2 ml B cell suspension 
(at 2 x 108cells/ml)arelayeredonto thegradient.Cellsarecentrifuged 
for 20 min at 400 x g and 20°C. While dead cells remain on the 
surface of 15% Percoll, low density B cells are collected on the surface 
of 60% Percoll. High density B cells that penetrate through the 60% 
Percoll are recovered. The resulting total tonsil B cells, high density 
B cells, and low density B cells were used for isolation of B cell subsets 
by immunomagnetic beads. 
Isolation of lgD+CD36- Naive B Cells by Magnetic Bead 
Depletion of CD38+lgWlgA+ B Cells 
High density Bcellsareincubated with mouseantibodiesagainst CD36 
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(OKTIO), IgG, and IgA in PBS containing 0.5% fetal calf serum (FCS) 
for 30 min. After washing twice, cells are incubated with Dynabeads 
M-450 coated with sheep anti-mouse IgG (Dynal, Oslo, Norway) at 
4OC for 30 min. The Dynabeads are prewashed and used at a ratio 
of 4 beads/cell. Finally, positive and negative cells are separated by 
a magnetic particle contractor, Dynal-MPC-I. The purity of naive B 
cells is checked by flow cytometry based on the expression of IgD 
and CD36. In some experiments, lgD+CD36- naive B cells were also 
isolated by positive selection of IgD+ B cells with immunomagnetic 
beads as described before (Briere et al., 1994). 
Isolation of lgDCD39+ GC B Calls by lmmunomagnatic Bead 
Daplatlon of IgD + and CD39+ B Calls 
Low density B cells are incubated with biotinylated goat anti-human 
IgDand biotinylatedmouseanti-humanCD39for30min.AWerwashing 
twice, cells are incubated with Dynabeads M-260 coated with streptavi- 
din (Dynal, Oslo, Norway) for 30 min. The Dynabeads are prewashed 
and used at a ratio of 4 beads/cell. Finally, positive and negative cells 
are separated by a magnetic particle contractor, Dynal-MPC-I. 
Isolation of IgD-CD39- Memory B Calls 
by Immunomagnatlc Bands 
Total tonsillar B cells are incubated with anti-IgD and anti-CD36 for 
30 min. After washing, cells are incubated with Dynabeads coated 
with anti-mouse IgG, and then IgD+ and CD36+ B cells are depleted 
by a magnetic particle contractor. 
Labeling of Cell Surface Antlgens 
Dlracf /mmunof/uorascenca Stalnlng 
Labeling was performed by using a panel of murine MAbs (Table 1) 
directly conjugated with phycoerythrin (PE) or fluorescein isothiocya- 
nate (FITC). In brief, cells were incubated with appropriate concentra- 
tion of antibody for 20 min at 4OC. After two washes with PBS con- 
taining 0.5% FCS and 2 mM sodium azide, cells were analyzed with 
a FACScan flow cytometer (see below). For intracellular Bcl-2 and 
nuclear Ki67 staining, cells were permeabilized by incubation with 0.3 
mg/ml saponin for 15 min at 4OC. 
fndlracf Immunofluorascence Stalnlng 
Labeling was performed with a panel of uncoupled or biotinylated 
murine MAbs, which were detected by FITC-conjugated sheep anti- 
mouse immunoglobulin F(ab’)P or PEconjugated streptavidin. In brief, 
cells were incubated with MAbs at appropriate concentrations for 20 
min at 4OC, then washed with PBS containing 0.5% FCS and 2 mM 
sodium azide. Cells were then incubated with FlTCconjugated sheep 
anti-mouse immunoglobulin F(ab’)P or streptavidin-PE for 20 min at 
4OC. Cells were subsequently washed twice in PBS and analyzed with 
a FACScan (see below). 
Double lmmunofluorescenca Sfalning 
Cells were sequentially incubated with two MAbs using two protocols: 
using two MAbs conjugated to FITC and PE; using one antibody conju- 
gated to FITC and one biotinylated antibody, which was then detected 
by PE-labeled streptavidin. 
Cyfofluorographk Analysis 
Cells were analyzed using a FACScan flow cytometer (Becton Dickin- 
son, Sunnyvale, California) equipped with an argon laser turned at 
466 nm emitting 15 mW. Residual dead cells and cell aggregates were 
excluded by low angle and orthogonal light scatter. A minimum of 
10,000 cells was examined per sample. FITC and PE spectral overlap 
was corrected with electronic compensation. FACS data were ana- 
lyzed with LYSIS I (Becton Dickinson) and expressed as percentage 
of fluorescent cells tested with the appropriate MAbs compared with 
nonrelevant antibodiesof identical isotypes. In addition, mean fluores- 
cence intensityof the positivecellswasmeasured asthemean channel 
number plotted on a logarithmic scale. 
Glemsa Staining and Analysis of Nuclear Antigen Kl67 
Cells(l06)from eachof the purified Bcell subsets werecytocentrifuged 
for 5 min at 500 rpm on a microscope slide. Slides were fixed in metha- 
nol for 5 min and then stained with Giemsa staining solution (BDH 
Limited, Poole, England) diluted I:5 with distilled water. Some slides 
were fixed in cold acetone at 4OC for 10 min for immunocytology. 
Slides were washed in PBS for 5 min and incubated with mouse MAbs 
against Ki67 antigen (DAKO, Glostrup, Denmark)for 45 min. The slides 
were washed twice in PBS and then incubated with sheep anti-mouse 
immunoglobulin (BDS, Birmingham, England). After 45 min. slides 
ware washed and incubated with mouse MAb against alkaline phos- 
phatase and alkaline phosphatase complexes (APAAP) (DAKO). After 
another 45 min, the slides were washed three times in PBS and the 
enzyme activity was developed by the fast red substrate (DAKO). 
Call Cultures 
Cells were cultured in RPM1 1640 medium containing 10% heat- 
inactivated FCS, 60 &ml gentamicine, and 2 mM glutamine (all from 
Flow Laboratories, Maclean, Virginia) at 37OC. To compare the ability 
of three subsets of B cells to produce anti-TT antibody, 5 x 104 cells 
of each subset were cultured with a cocktail of IL-2 (20 U/ml). IL-IO 
(100ng/ml),andSAC(0605%)in theCD4Osystemfor lOdays(Banch- 
ereau et al., 1991). Levels of IgG anti-TT antibody were quantified by 
enzyme-linked immunosorbent assay (ELISA) and expressed as mU/ 
ml. The other culturing conditions used for analyzing alloreaction and 
regulation of 87-l and 87-2 expressions by anti-immunoglobulin and 
CD40-ligand are detailed in the figure legends. 
Immunohlstology 
Portions Of tonsil were snap frozen in liquid nitrogen and stored at 
-7O“C. Frozen sections (5 urn) were cut and mounted on glass slides. 
They were thoroughly dried at room temperature for at least 1 hr and 
were fixed in acetone at 4OC for 15 min. Sections were stained by 
double immunoenzyme technique, using the biotin-avidin-peroxidase 
system and alkaline phosphatase-anti-alkaline phosphatase system 
(APAAP technique). In brief, sections were washed in PBS for 5 min. 
Then, one section was incubated with goat anti-human IgD-biotin and 
mouse anti-human CD36 (Table 1); while a serial section was incu- 
bated with mouse anti-human IgD (IgGl isotype), mouse anti-human 
CD36 (IgG1 isotype), and mouse anti-human CD20 (IgM isotype). Fol- 
lowing washing, the first section was incubated with streptavidine- 
peroxidase and sheep anti-mouse immunoglobulin; while the serial 
section was incubated with sheep anti-mouse IgM-biotin and sheep 
anti-mouse IgGl. Then, the first section was incubated with alkaline 
phosphatase coupled to mouse antibodies specific for alkaline phos- 
phatase (APAAP complexes); while the second section was incubated 
with streptavidine-peroxidase and APAAP complexes. After a final 
washing, peroxidase was developed by 3-amino-9ethylcarbazole. 
which gives a red color, and alkaline phosphatase was developed by 
fast blue substrate, which gives a blue color (Liu et al., 1966). 
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